Results 291 to 300 of about 204,688 (384)

Risk factors affecting the incidence of CMV infection in recipients after living donor liver transplantation. [PDF]

BMC Gastroenterol
Elfors MA, Helmy MGE, Mahmoud HEA, Hussein MM, Naguib AM, Ahmed MBED, Elbaz HSI, Aly Aly MO.   +7 more
europepmc   +1 more source

A COMPARISON OF CYCLOSPORINE A AND Nva2-CYCLOSOPORINE (CYCLOSPORINE G) IN A RAT RENAL ALLOGRAFT MODEL

, 1987
David A. Grant, Robert Zhong, C Stiller, Cameron Wallace, Paul Keown, John Duff   +5 more
openalex   +1 more source

Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network

Transplant Infectious Disease, EarlyView.
ABSTRACT Introduction In nonendemic areas, transplantation from donors with hepatitis B virus (HBV) to recipients without HBV (D+/R−) has been proposed to expand the donor pool; however, data are limited. We aimed to evaluate the epidemiology of HBV in thoracic organ donors, assess HBV‐related thoracic organ nonuse, and determine the impact of HBV D+/R−
Sara Belga, Robert C. Wright, Stephen B. Lee, Christine M. Durand, Karen Doucette   +4 more
wiley   +1 more source

Editorial: Benefit and risk on drug-drug interactions in infections. [PDF]

Front Microbiol
Kato H, Asai N, Hagihara M.
europepmc   +1 more source

Cyclosporine measurement by fluorescent polarization immunoassay utilizing Abbott TD(x)® instrument [PDF]

, 1989
Diven, WF, Sanghvi, A, Starzl, T, Warty, VS   +3 more
core  

Longitudinal Innate and Heterologous Adaptive Immune Responses to SARS‐CoV‐2 JN.1 in Transplant Recipients With Prior Omicron Infection: Limited Neutralization but Robust CD4+ T‐Cell Activity

Transplant Infectious Disease, EarlyView.
In transplant recipients with prior Omicron infection, neutralizing antibodies against JN.1 were limited and often absent 1 year later. However, robust and durable CD4⁺ T‐cell responses were consistently observed, suggesting that cellular immunity may offer sustained protection against emerging SARS‐CoV‐2 variants, despite modest antibody responses ...
Victor H. Ferreira, Brandon Keith, Faranak Mavandadnejad, Alejandro Ferro, Sara Marocco, Golnaz Amidpour, Alexandra Kurtesi, Freda Qi, Anne‐Claude Gingras, Victoria G. Hall, Deepali Kumar, Atul Humar   +11 more
wiley   +1 more source

The development of immunosuppression in the renal model [PDF]

, 1984
Iwatsuki, S, Shaw, BW, Starzl, TE
core  

Autoantibodies against TRIM46 identified in a dog suffering from suspected meningoencephalomyelitis of unknown origin

Journal of Small Animal Practice, EarlyView.
P. L. Heidemann, A. C. Nilsson, S. G. Schmidt, E. Lattwein, C. Allberg, M. Blaabjerg, H. Gredal   +6 more
wiley   +1 more source

Prognostic Impact of Cytomegalovirus Reactivation After Transplantation From Cord Blood Compared to Other Donor Sources in Patients With Adult T‐Cell Leukemia/Lymphoma in the Pre‐Letermovir Era

Transplant Infectious Disease, EarlyView.
Cytomegalovirus reactivation (CMV‐react) is an indicator to predict the increased non‐relapse mortality and decreased overall survival in adult T‐cell leukemia‐lymphoma patients who received allogeneic transplantation from HLA‐matched related and unrelated donors.
Takuya Fukushima, Hidehiro Itonaga, Hikaru Sakamoto, Wataru Takeda, Masahito Tokunaga, Takeharu Kato, Takuro Kuriyama, Toshiro Kawakita, Machiko Fujioka, Yasuhiko Miyazaki, Naoyuki Uchida, Yasuo Mori, Hirohisa Nakamae, Masao Ogata, Kazunori Imada, Makoto Onizuka, Kazuho Morichika, Yoshinobu Kanda, Takahiro Fukuda, Yoshiko Atsuta, Shigeo Fuji, Makoto Yoshimitsu, ATL Working Group of the Japanese Society for Transplantation and Cellular Therapy   +22 more
wiley   +1 more source

Systemic Immunomodulatory Therapy in Uveitis Related to Behçet's Disease: A 10-year Profile. [PDF]

Clin Ophthalmol
Almeida M, Ferreira AM, Araújo JR, Figueira L.   +3 more
europepmc   +1 more source